Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 8:30:101245.
doi: 10.1016/j.bbrep.2022.101245. eCollection 2022 Jul.

Administration of retinoic acid to pregnant mice increases the number of fetal mouse glomeruli

Affiliations

Administration of retinoic acid to pregnant mice increases the number of fetal mouse glomeruli

Shohei Fukunaga et al. Biochem Biophys Rep. .

Abstract

The prevalence of chronic kidney disease (CKD) is increasing worldwide, and CKD is a serious global health problem. Low glomerular number is one of the risk factors for CKD; therefore, the glomerular number is associated with the risk of CKD. Increasing the glomerular number above normal levels may reduce the risk of CKD. It has been reported that, in vitro, the addition of retinoic acid (RA) to the culture medium increases the glomerular number. However, there is no report of an increase in glomerular number above normal levels with the addition of RA in vivo. In this study, RA (20 mg/kg) was administered intraperitoneally to pregnant mice once at embryonic day (E) 10.5, E12.5, E14.5, or E16.5. The fetuses were harvested at E18.5 and fetal mouse kidneys were evaluated. Fetal kidney volume and weight were significantly increased in the E16.5 group compared to the control group. The total glomerular number in the E16.5 group was also approximately 1.46 times higher than that in the control group. In summary, we established a method to increase the glomerular number in the fetal kidney by administration of RA to pregnant mice at E16.5. These results will facilitate the investigation of whether CKD risk is reduced when the glomerular number increases above normal.

Keywords: CKD, chronic kidney disease; Chronic kidney disease; E, embryonic day; GA, glomerular area; GV, glomerular volume; Glomerular number; Mouse fetus; RA, retinoic acid; Retinoic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Body weight, kidney weight, and kidney volume in fetuses treated with retinoic acid The control group received corn oil intraperitoneally at E10.5. Experimental groups received retinoic acid (RA) intraperitonially once at E10.5, E12.5, E14.5, or E16.5. Fetuses were harvested at E18.5, and the fetal body weight, kidney volume, and kidney weight were compared. (A) Fetal weight, kidney volume, and kidney weight were measured in all the fetuses (n = 33 fetuses in the control group, 53 fetuses in the E10.5 group, 40 fetuses in E12.5 group, 44 fetuses in the E14.5 group, and 37 fetuses in the E16.5 group). There was no difference in fetal body weight between the control group and the RA groups. (B) Kidney volume was compared after normalizing it to fetal body weight. The E16.5 group had a larger kidney volume than the control group (6.82 ± 0.19 mL/g vs. 8.31 ± 0.18 mL/g, p < 0.0001). (C) Kidney weight was compared after normalizing it to fetal body weight. The E14.5 group (8.45 ± 0.12 mg/g vs. 8.91 ± 0.16 mg/g, p = 0.0364) and the E16.5 group (8.45 ± 0.12 mg/g vs. 9.895 ± 0.16 mg/g, p < 0.0001) had significantly higher kidney weight than the control group. ns: not significant, *P < 0.05, ****P < 0.0001. The error bars represent standard errors of the mean (SEMs). RA: Retinoic acid, E: Embryonic day.
Fig. 2
Fig. 2
Fetal kidneys dissected at E18.5 (A–E) Images showing fetal kidneys dissected at E18.5 of the control group (A) and the E10.5 (B), E12.5 (C), E14.5 (D), and E16.5 (E) groups. All images are kidneys taken from fetuses closest to the average fetal body weight (scale bar, 2 mm). The kidneys in the E16.5 group were macroscopically larger than those in the control group. RA: Retinoic acid, E: Embryonic day.
Fig. 3
Fig. 3
Histological analysis and glomerular number per unit area (A, B) Micrographs of fetal kidneys after hematoxylin-eosin staining. The largest cross-sectional slice of kidney in the E16.5 group (B) was larger than that of the control group (A) (scale bar, 0.5 mm). (C) There was no significant difference in the glomerular number per unit area between the control group and the E16.5 group (n = 3 kidneys in the control group and 3 kidneys in the E16.5 group, 25.98 ± 1.66 pieces/mm2 vs. 29.23 ± 1.83 pieces/mm2, p = 0.2083). (D) There was no significant difference in the glomerular volume between the control group and the E16.5 group (n = 15 glomeruli in the control group and 15 glomeruli in the E16.5 group, 16.16 ± 1.42 × 104 μm3 vs. 16.25 ± 1.12 × 104 μm3, p = 0.9606). ns: not significant. The error bars represent standard errors of the mean (SEMs). RA: Retinoic acid, E: Embryonic day.
Fig. 4
Fig. 4
Glomerular number per kidney The total glomerular number per kidney in the E16.5 group was significantly higher than that in the control group (n = 3 kidneys in the control group and 3 kidneys in the E16.5 group, 1557 ± 175.2 vs. 2270 ± 126.6, p = 0.0300). *P < 0.05. The error bars represent standard errors of the mean (SEMs). RA, retinoic acid; E, embryonic day.

Similar articles

Cited by

References

    1. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed
    1. Liyanage T., Ninomiya T., Jha V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982. doi: 10.1016/S0140-6736(14)61601-9. - DOI - PubMed
    1. Mañalich R., Reyes L., Herrera M., et al. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 2000;58:770–773. doi: 10.1046/j.1523-1755.2000.00225.x. - DOI - PubMed
    1. Silver L.E., Decamps P.J., Korst L.M., et al. Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am. J. Obstet. Gynecol. 2003;188:1320–1325. doi: 10.1067/mob.2003.270. - DOI - PubMed
    1. White S.L., Perkovic V., Cass A., et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am. J. Kidney Dis. 2009;54:248–261. doi: 10.1053/j.ajkd.2008.12.042. - DOI - PubMed

LinkOut - more resources